 |
인쇄하기
취소
|
Ildong wins Korean patents for antihypertensive agents
Ildong Pharm said on November 16 that it acquired from the Korean Intellectual Property Office two patents for candesartan cilexetil and valsartan, respectively, for the treatment of hypertension.
The two patents related to more improved manufacturing process of active ingredients in the absence of harmful solvents.
So far, the company has endeavored to develop angiotensin II receptor ant...
The two patents related to more improved manufacturing process of active ingredients in the absence of harmful solvents.
So far, the company has endeavored to develop angiotensin II receptor ant...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.